Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Stomach Neoplasms 4Gastritis 4Peptic Ulcer 3Dyspepsia 3Lymphoma, B-Cell, Marginal Zone 2Unspecified Adult Solid Tumor, Protocol Specific 1Stomach Ulcer 1Rosacea 1Meibomian Gland Dysfunction 1Lymphoma, Non-Hodgkin 1Lymphoma 1Lung Neoplasms 1Gastritis Dyspepsia Helicobacter Pylori Infection Gastric Cancer Peptic Ulcer 1Exanthema 1Dysbiosis 1Chalazion 1Ameloblastoma 1

Interventions

Carboplatin 177Radiotherapy 139Cisplatin 110Pemetrexed 102Docetaxel 93Paclitaxel 92Gemcitabine 78Erlotinib Hydrochloride 73Magnetic Resonance Spectroscopy 72Radiosurgery 67Bevacizumab 65pembrolizumab 64Etoposide 60Blood Specimen Collection 60durvalumab 53Specimen Handling 48Nivolumab 48Surveys and Questionnaires 47Drug Therapy 41Standard of Care 35Radiation 33osimertinib 32atezolizumab 32Surgical Procedures, Operative 30Topotecan 29Irinotecan 29Gefitinib 29Educational Status 29Early Intervention, Educational 29Biopsy 28

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Lung Neoplasms × Tetracycline × Clear all
NCT01880515 2025-05-11

Tetracycline as a Prophylaxis for Rash in Patients With NSCLC Receiving Treatment With BIBW2992 (Afatinib)

Instituto Nacional de Cancerologia de Mexico

Phase 2 Completed
107 enrolled 8 charts
Thoracic

Exanthema, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡